Audris H.

Audris H. currently serves as Global Regulatory Lead at Genmab since June 2023, focusing on the Oncology therapeutic area and solid tumors, notably co-leading the regulatory strategy and submission for Tivdak in collaboration with Pfizer. Prior experience includes a 14-year tenure at Bristol Myers Squibb, where Audris held various positions, advancing from Global Regulatory Manager to Global & US Regulatory Lead in the Hematology therapeutic area. Key achievements include leading the successful FDA approval of Reblozyl and overseeing multiple FDA meetings for crucial submissions. Audris's career began at Pharmacia & Upjohn as a Medicinal Chemist in antiviral drug discovery. Educational qualifications include a Ph.D. in Organic Chemistry from UC Irvine, a B.S. in Chemistry from the University of Illinois Urbana-Champaign, and completion of a NIH Postdoctoral Fellowship at Stanford University.